作者: Vanessa Piras , Paolo Usai , Silvia Mezzena , Marta Susnik , Francesca Ideo
DOI: 10.1016/J.JOEN.2016.11.004
关键词:
摘要: Abstract Aim We evaluated the prevalence of apical periodontitis (AP) and oral health status in patients with inflammatory bowel diseases (IBDs) treated immunomodulators, particular attention to biologic medications (BMs). Methods One hundred ten patients, 49 men 61 women (average age, 46 ± 13.8 years), from Gastroenterology Unit University Hospital IBDs who were BMs or corticosteroids included study. registered for a dental check-up at Dental Clinic matched sex, physical characteristics study group without systemic not taking control. Patients underwent complete oral, dental, radiographic examination. Decayed, missing, filled teeth periapical index score indexes recorded. Student t test, χ 2 , Mann-Whitney U test used as appropriate. Results The AP was 64% IBD 59% control; according gender-stratified analysis, difference significant among male groups, whereas number significantly higher female than controls ( P ≤ .05). 65%; showed 69% risk presented similar both had controls. Conclusions Women immunomodulators AP. All larger lesions healthy subjects. These data emphasize influence immune system onset need further studies confirm these findings.